Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Infused Autograft Lymphocyte to Monocyte Ratio and Survival in Classical Hodgkin Lymphoma

Luis F. Porrata, MD, David J. Inwards, MD, Stephen M. Ansell, MD PhD, Ivana N. Micallef, MD, Patrick B. Johnston, MD PhD, William Hogan, MD, Svetomir N. Markovic, MD, PhD

Blood (2014) 124 (21): 1189.

https://doi.org/10.1182/blood.V124.21.1189.1189

Published: 2014

Journal Articles

Extracorporeal Photophoresis (ECP) For Chronic Graft Versus Host Disease (cGVHD): A Systemic Review and Meta-Analysis

Shahrukh K Hashmi, MD, Mohsin Malik, MD, Hassan Murad, MD MPH, Larry Prokop, MLS, William Hogan, MD, Mrinal M Patnaik, MBBS, Jeffrey L. Winters, MD, Mark R. Litzow, MD

Blood (2013) 122 (21): 5472.

https://doi.org/10.1182/blood.V122.21.5472.5472

Published: 2013

Journal Articles

Correlation Of Outcomes Of Allogeneic Stem Cell Transplants For Chronic Myelomonocytic Leukemia With The Mayo Prognostic Model

Michelle T Patzelt, BS, Mark R. Litzow, MD, William Hogan, MD, Shahrukh K Hashmi, MD, Michelle Elliott, MD, Aref Al-Kali, MD, Mrinal M. Patnaik, MBBS

Blood (2013) 122 (21): 5226.

https://doi.org/10.1182/blood.V122.21.5226.5226

Published: 2013

Journal Articles

Baseline Spleen Size and Mutations Involving ASXL1 and SRSF2 Predict Survival and Treatment Response In JAK Inhibitor Treated Myelofibrosis Patients

Animesh Pardanani, MBBS, PhD, Ramy A Abdelrahman, MBBCh, Kebede Begna, MD, Darci Zblewski, RN, CNP, Aref Al-Kali, MD, Mrinal M. Patnaik, MBBS, William Hogan, MD, Terra L Lasho, MT, (ASCP), Christy Finke, BS, Curtis A. Hanson, MD, Mark R. Litzow, MD, Ayalew Tefferi, MD

Blood (2013) 122 (21): 4048.

https://doi.org/10.1182/blood.V122.21.4048.4048

Published: 2013

Journal Articles

Retrospective Comparison Of Survival and Leukemic Transformation In Myelofibrosis Patients Treated With Ruxolitinib Versus Momelotinib Versus Fedratinib Versus Pomalidomide

Animesh Pardanani, MBBS, PhD, Ramy A. Abdelrahman, MBBCh, Kebede Begna, MD, Darci Zblewski, RN, CNP, Aref Al-Kali, MD, Mrinal M. Patnaik, MBBS, William Hogan, MD, Curtis A. Hanson, MD, Mark R. Litzow, MD, Ayalew Tefferi, MD

Blood (2013) 122 (21): 4049.

https://doi.org/10.1182/blood.V122.21.4049.4049

Published: 2013

Journal Articles

Monosomal Karyotype Predicts Adverse Prognosis In Patients With Chronic Myelomonocytic Leukemia

Aysha K Alsahlawi, Hassan Alkhateeb, MD, Mrinal M. Patnaik, MBBS, Kebede Begna, MD, Michelle Elliott, MD, William Hogan, MD, Rhett P Ketterling, Mark R. Litzow, MD, Aref Al-Kali, MD

Blood (2013) 122 (21): 1334.

https://doi.org/10.1182/blood.V122.21.1334.1334

Published: 2013

Journal Articles

Immune Profiling To Predict Treatment Response From Extracorporeal Photopheresis In Graft-Versus-Host Disease

Deepti M. Warad, M.B.B.S., Stefan F Cordes, MD, PhD, Michael Gustafson, PhD, Douglas Padley, Adam S. Armstrong, Greg Butler, Mrinal M. Patnaik, MBBS, William Hogan, MD, Mark R. Litzow, MD, Jeffrey L. Winters, MD, Dennis A. Gastineau, MD, Allan B Dietz, PhD, Yi Lin, MDPhD, Eapen K. Jacob, MD

Blood (2013) 122 (21): 3260.

https://doi.org/10.1182/blood.V122.21.3260.3260

Published: 2013

Journal Articles

Hepatic and Metabolic Complications In Adult Patients With Acute Lymphoblastic Leukemia (ALL) Treated With Asparaginase-Containing Combination Chemotherapy: A Single Center Experience

Jason N. Barreto, PharmD, Kristen B. McCullough, PharmD, Candy S Peskey, PharmD, Louis Letendre, MD, William Hogan, MD, Aref Al-Kali, MD, Mark R. Litzow, MD, Mrinal M. Patnaik, MBBS

Blood (2013) 122 (21): 1405.

https://doi.org/10.1182/blood.V122.21.1405.1405

Published: 2013

Journal Articles

Chronic Graft Vs Host Disease Is The Strongest Predictor Of Outcome After Reduced Intensity Conditioning Stem Cell Transplantation In Chronic Lymphocytic Leukemia and Is Associated With Pretransplant B Cell Characteristics

Saad Sirop Kenderian, MD, Ruchi G. Sharma, Mrinal M Patnaik, MD, Timothy G. Call, MD, Shahrukh K Hashmi, MD, Neil E. Kay, MD, Wei Ding, MD, PhD, Mark R. Litzow, MD, Kari G. Rabe, MS, William Hogan, MD, Tait D. Shanafelt, M.D.

Blood (2013) 122 (21): 3375.

https://doi.org/10.1182/blood.V122.21.3375.3375

Published: 2013

Journal Articles

Clonal Evolution As Determined By Sequential Bone Marrow Karyotype Analysis During JAK Inhibitor Therapy For Myelofibrosis: Impact On Treatment Response and Overall and Leukemia-Free Survival

Ramy A. Abdelrahman, MBBCh, Kebede Begna, MD, Darci Zblewski, RN, CNP, Aref Al-Kali, MD, Mrinal M. Patnaik, MBBS, William Hogan, MD, Ryan A Knudson, Rhett P Ketterling, Curtis A. Hanson, MD, Mark R. Litzow, MD, Ayalew Tefferi, MD, Animesh Pardanani, MBBS, PhD

Blood (2013) 122 (21): 2821.

https://doi.org/10.1182/blood.V122.21.2821.2821

Published: 2013

Journal Articles

Thromboembolic and Hemorrhagic Complications In Adult Patients With Acute Lymphoblastic Leukemia (ALL) Treated With Asparaginase-Containing Combination Chemotherapy: A Single Center Experience

Jason N. Barreto, PharmD, Kristen B. Mccullough, PharmD, Candy S. Peskey, PharmD, Michelle Elliott, MD, Dennis A. Gastineau, MD, Aref Al-Kali, MD, Louis Letendre, MD, William Hogan, MD, Mark R. Litzow, MD, Mrinal M. Patnaik, MBBS

Blood (2013) 122 (21): 3873.

https://doi.org/10.1182/blood.V122.21.3873.3873

Published: 2013

Journal Articles

Voriconazole Exposure and The Risk Of Cutaneous Squamous Cell Carcinoma In Allogeneic Hematopoietic Stem Cell Transplant Patients

Shahrukh K Hashmi, MD, Daniel Wojenski, Pharm.D R.Ph, Gabriel Bartoo, Pharm.D R.Ph, Julianna A. Merten, Pharm.D., Ross Dierkhising, M.S., Rokea Elazhary, MD PhD, John W Wilson, MD, Robert Wolf, Pharm.D., Mrinal M. Patnaik, MBBS, William Hogan, MD, Mark R. Litzow, MD

Blood (2013) 122 (21): 916.

https://doi.org/10.1182/blood.V122.21.916.916

Published: 2013

Journal Articles

Treatment-Related AML Patients Previously Treated with Taxanes for Breast Cancer Have Similar Outcomes As De Novo AML

Lindsey E. Roeker, Alexandra Wolanskyj, MD, Michelle Elliott, William Hogan, MD, Mark Litzow, MD, Aref Al-Kali, MD

Blood (2012) 120 (21): 3555.

https://doi.org/10.1182/blood.V120.21.3555.3555

Published: 2012

Journal Articles

Loss of the Y Chromosome Predicts Lower Complete Cytogenetic Remission Rate in Patients (pts) with Chronic Myeloid Leukemia (CML)

Mohamed Abdelfatah, Adel Al-Alwan, Zeyad Kanaan, Mark R Litzow, MD, Alexandra Wolanskyj, Kebede Begna, William Hogan, MD, Daniel L. Van Dyke, Ph.D., Aref Al-Kali, MD

Blood (2012) 120 (21): 4804.

https://doi.org/10.1182/blood.V120.21.4804.4804

Published: 2012

Journal Articles

Doxycycline Used As Post Transplant Antibacterial Prophylaxis Improves Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Stem Cell Transplantation.

Shaji K. Kumar, MD, Angela Dispenzieri, MD, Martha Q Lacy, MD, Suzanne R Hayman, MD, Francis K Buadi, M.D., David Dingli, M.D., Ph.D., Steven R Zeldenrust, MD, PhD, Marina Ramirez-Alvarado, Ph.D., Prashant Kapoor, MD, William Hogan, MD, S. Vincent Rajkumar, MD, Morie A Gertz

Blood (2012) 120 (21): 3138.

https://doi.org/10.1182/blood.V120.21.3138.3138

Published: 2012

Journal Articles

Allogeniec Stem Cell Transplantation for Primary and Post ET/PV Myelofibrosis At Mayo Clinic: A Retrospective Review Across a Geographically Diverse 3 Site Cancer Center.

Veena Devi Salem Fauble, MD, James L Slack, MD, William Hogan, MD, Vivek Roy, M.D., Jose Leis, MD, PhD, Amylou C. Dueck, PhD, Mark R Litzow, MD, Mrinal M. Patnaik, MBBS, MD, Pardanani Animesh, MBBS, PhD, Candido E. Rivera, MD, Raoul Tibes, MD, PhD, John Camoriano, MD, Roberta H. Adams, MD, Pierre Noel, MD, Nandita Khera, MD, Lisa Sproat, MD, MSW, Ruben A. Mesa

Blood (2012) 120 (21): 2850.

https://doi.org/10.1182/blood.V120.21.2850.2850

Published: 2012

Journal Articles

Cost Effectiveness Decision Tree Analysis of Early Versus Late Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) in the United States (US)

Shahrukh Hashmi, MD, MPH, Chintan Pandya, MD MPH, Morie A Gertz, M.D., Angela Dispenzieri, MD, William Hogan, MD, Mustaqeem A Siddiqui, MD, Nandita Khera, MD, Katia Noyes, MS MPH PhD, Shaji K. Kumar, MD

Blood (2012) 120 (21): 602.

https://doi.org/10.1182/blood.V120.21.602.602

Published: 2012

Journal Articles

A Risk Adapted Approach Utilizing Plerixafor in Autologous Peripheral Blood Stem Cell Mobilization.

Ivana Micallef, Stephen M Ansell, Francis Buadi, David Dingli, M.D., PhD., Angela Dispenzieri, Dennis Gastineau, Morie Gertz, Suzanne R. Hayman, MD, William Hogan, MD, David J Inwards, Patrick L Johnston, MD, PhD, Shaji Kumar, MD, Martha Q. Lacy, MD, Mark R. Litzow, MD, Luis Porrata, MD, Robert Wolf, PharmD, Teresa Miceli, Jeff Winters

Blood (2009) 114 (22): 3211.

https://doi.org/10.1182/blood.V114.22.3211.3211

Published: 2009

Journal Articles

Predicting Poor Peripheral Blood Stem Cell Mobilization Using Initial Peripheral CD34 Counts in Patients with Lymphoma.

Shirshendu Sinha, MBBS, Shaji Kumar, MD, Dennis A. Gastineau, MD, William Hogan, MD, Francis Buadi, MD, David Dingli, PhD., M.D., Angela Dispenzieri, MD, Morie A Gertz, MD, Carl Greiner, Suzzane Hayman, MD, David Inwards, MD, Patrick B Johnston, MD, PhD, Martha Q. Lacy, MD, Mark R. Litzow, MD, Luis F. Porrata, MD, Jeffrey Winters, MD, Ivana N Micallef, MD

Blood (2009) 114 (22): 4228.

https://doi.org/10.1182/blood.V114.22.4228.4228

Published: 2009

Journal Articles

Absolute Lymphocyte Count Assessed During Routine Follow-up Is a Risk Factor for Relapse Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation in Patients with Diffuse Large B-Cell Lymphoma.

Luis Porrata, MD, David J Inwards, Stephen M Ansell, Ivana Micallef, Patrick L Johnston, MD, PhD, William Hogan, MD, Svetomir Markovic

Blood (2009) 114 (22): 4359.

https://doi.org/10.1182/blood.V114.22.4359.4359

Published: 2009

NARROW

Infused Autograft Lymphocyte to Monocyte Ratio and Survival in Classical Hodgkin Lymphoma

Extracorporeal Photophoresis (ECP) For Chronic Graft Versus Host Disease (cGVHD): A Systemic Review and Meta-Analysis

Correlation Of Outcomes Of Allogeneic Stem Cell Transplants For Chronic Myelomonocytic Leukemia With The Mayo Prognostic Model

Baseline Spleen Size and Mutations Involving ASXL1 and SRSF2 Predict Survival and Treatment Response In JAK Inhibitor Treated Myelofibrosis Patients

Retrospective Comparison Of Survival and Leukemic Transformation In Myelofibrosis Patients Treated With Ruxolitinib Versus Momelotinib Versus Fedratinib Versus Pomalidomide

Monosomal Karyotype Predicts Adverse Prognosis In Patients With Chronic Myelomonocytic Leukemia

Immune Profiling To Predict Treatment Response From Extracorporeal Photopheresis In Graft-Versus-Host Disease

Hepatic and Metabolic Complications In Adult Patients With Acute Lymphoblastic Leukemia (ALL) Treated With Asparaginase-Containing Combination Chemotherapy: A Single Center Experience

Chronic Graft Vs Host Disease Is The Strongest Predictor Of Outcome After Reduced Intensity Conditioning Stem Cell Transplantation In Chronic Lymphocytic Leukemia and Is Associated With Pretransplant B Cell Characteristics

Clonal Evolution As Determined By Sequential Bone Marrow Karyotype Analysis During JAK Inhibitor Therapy For Myelofibrosis: Impact On Treatment Response and Overall and Leukemia-Free Survival

Thromboembolic and Hemorrhagic Complications In Adult Patients With Acute Lymphoblastic Leukemia (ALL) Treated With Asparaginase-Containing Combination Chemotherapy: A Single Center Experience

Voriconazole Exposure and The Risk Of Cutaneous Squamous Cell Carcinoma In Allogeneic Hematopoietic Stem Cell Transplant Patients

Treatment-Related AML Patients Previously Treated with Taxanes for Breast Cancer Have Similar Outcomes As De Novo AML

Loss of the Y Chromosome Predicts Lower Complete Cytogenetic Remission Rate in Patients (pts) with Chronic Myeloid Leukemia (CML)

Doxycycline Used As Post Transplant Antibacterial Prophylaxis Improves Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Stem Cell Transplantation.

Allogeniec Stem Cell Transplantation for Primary and Post ET/PV Myelofibrosis At Mayo Clinic: A Retrospective Review Across a Geographically Diverse 3 Site Cancer Center.

Cost Effectiveness Decision Tree Analysis of Early Versus Late Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) in the United States (US)

A Risk Adapted Approach Utilizing Plerixafor in Autologous Peripheral Blood Stem Cell Mobilization.

Predicting Poor Peripheral Blood Stem Cell Mobilization Using Initial Peripheral CD34 Counts in Patients with Lymphoma.

Absolute Lymphocyte Count Assessed During Routine Follow-up Is a Risk Factor for Relapse Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation in Patients with Diffuse Large B-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only